Skip to content
PatentBrief
Get alertsTop ↑

How Circular Probes Find Specific DNA in Cells

This patent describes a method using special circular DNA probes and enzymes to precisely detect specific genetic sequences within a cell or tissue sample, then amplifies the detected sequences for clear viewing.

Granted 2026ActiveExpires 2042

Original patent title: “Circular probes and methods for sample analysis”

Plain-English explanation by SahiLast reviewed · October 2, 2026

This patent describes a method using special circular DNA probes and enzymes to precisely detect specific genetic sequences within a cell or tissue sample, then amplifies the detected sequences for clear viewing. Granted in 2026.

Coverage

What does this patent actually cover?

This method analyzes target nucleic acids, like DNA or RNA, within a cell or tissue. It uses circular probes, such as "dumbbell probes," that are designed to bind only to a specific target sequence. After the probes are introduced, an enzymatic treatment is applied. This treatment destroys any circular probes that did not bind to their target or bound incorrectly, effectively cleaning up the sample. The circular probes that successfully bound to their target nucleic acid remain intact. These intact, bound probes are then amplified using a process called rolling circle amplification (RCA), which creates many copies of the circular probe's sequence, making the target detectable. For example, a researcher could use this to find a specific viral DNA sequence inside infected cells.

The gap

What does this patent NOT cover?

  • Does not cover methods that use linear probes instead of circular probes for target nucleic acid detection.
  • Does not cover analysis methods that do not include an enzymatic step to remove unbound or non-specifically bound probes.
  • Does not cover detection systems that do not rely on rolling circle amplification (RCA) to visualize the target.
  • Does not cover the analysis of targets other than nucleic acids, such as proteins or lipids.
  • Does not cover methods where the target nucleic acid is analyzed outside of its original cellular or tissue context (i.e., not "in situ").

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

Key facts

Patent numberUS 12735738
StatusActive
FieldBiotech & Medicine
Filed2022
Granted2026
Times cited0
LitigationNone on record
Value · $36K–$115KMinimal

What made this novel

The clever part is combining circular probes with an enzymatic step that specifically destroys only the unbound or incorrectly bound probes. This dramatically reduces background signal, ensuring that only the truly specific binding events are amplified and detected, leading to much clearer and more reliable results.

Circular probes and methods fo…(Primary claim)biotechdiagnosticsresearch toolsgene editing

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Detecting specific viral DNA in infected human tissue samples

02

Identifying gene expression patterns in cancer cells

03

Mapping RNA molecules within a neuron

04

Diagnosing bacterial infections by finding their unique DNA sequences

05

Studying genetic variations in individual cells

Why it matters

The bigger picture

Precisely detecting specific nucleic acid sequences within cells or tissues is crucial for understanding diseases like cancer and infections, and for basic biological research. This method aims to improve the accuracy and clarity of such detection by reducing background noise from non-target binding. It provides a tool for scientists to visualize exactly where and how much of a particular genetic material is present in a biological sample.

Filed

November 23, 2022

Granted

September 15, 2026

Market context

Who's building on this

Companies in this space

Companies in the molecular diagnostics and life science research tools space are actively developing and refining technologies for in situ nucleic acid detection. Major players like Thermo Fisher Scientific, Illumina, and Bio-Rad Laboratories, along with numerous specialized startups, are continuously innovating in areas related to probe design, enzymatic amplification, and imaging techniques to improve sensitivity and specificity for genetic analysis.

Market impact

This type of technology contributes to the ongoing advancement of molecular diagnostics and basic biological research. By offering improved specificity and signal-to-noise ratios, it can enable more accurate disease detection and a deeper understanding of cellular processes. This could lead to the development of new diagnostic tests and research assays, potentially influencing fields from oncology to infectious disease surveillance by providing clearer insights into genetic material within its native context.

Claim 1 — Plain English

What this patent covers

This method analyzes target nucleic acids, like DNA or RNA, within a cell or tissue. It uses circular probes, such as "dumbbell probes," that are designed to bind only to a specific target sequence. After the probes are introduced, an enzymatic treatment is applied. This treatment destroys any circular probes that did not bind to their target or bound incorrectly, effectively cleaning up the sample. The circular probes that successfully bound to their target nucleic acid remain intact. These intact, bound probes are then amplified using a process called rolling circle amplification (RCA), which creates many copies of the circular probe's sequence, making the target detectable. For example, a researcher could use this to find a specific viral DNA sequence inside infected cells.

The clever bit

The clever part is combining circular probes with an enzymatic step that specifically destroys only the unbound or incorrectly bound probes. This dramatically reduces background signal, ensuring that only the truly specific binding events are amplified and detected, leading to much clearer and more reliable results.

What it does not cover

  • Does not cover methods that use linear probes instead of circular probes for target nucleic acid detection.
  • Does not cover analysis methods that do not include an enzymatic step to remove unbound or non-specifically bound probes.
  • Does not cover detection systems that do not rely on rolling circle amplification (RCA) to visualize the target.
  • Does not cover the analysis of targets other than nucleic acids, such as proteins or lipids.
  • Does not cover methods where the target nucleic acid is analyzed outside of its original cellular or tissue context (i.e., not "in situ").

Patent timeline

Filing

Application submitted to the patent office

Grant

Patent officially issued

PatentBrief Score

Impact Score

Early stage

Citation count

0/40

No citations yet

Claim breadth

0/20

Narrow claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

20/20

Granted within 5 years

Assignee scale

0/20

Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Minimal

$36K – $115K

Midpoint $72K · 16.1 yr remaining · industry ×3.0

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

Claim text not yet imported for this patent

Claim text not yet imported for this patent.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Cite this patent

(2026). How Circular Probes Find Specific DNA in Cells (U.S. Patent No. 12,735,738). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/12735738/circular-probes-and-methods-for-sample-analysis

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US12735738"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4965188 · 1990

How to Make Many Copies of a DNA Piece with Heat

This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.

Cetus Corp

US 4235871 · 1980

How to Encapsulate Active Materials in Lipid Bubbles Efficiently

This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.

Individual

Semantically similar

You might also find these interesting

SEARCH ALL

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary
Explore the landscape:biotech patents →diagnostics patents →research tools patents →

Common Questions

Frequently Asked Questions

What does How Circular Probes Find Specific DNA in Cells cover?

This patent describes a method using special circular DNA probes and enzymes to precisely detect specific genetic sequences within a cell or tissue sample, then amplifies the detected sequences for clear viewing.

When does this patent expire?

This patent is expected to expire on September 15, 2046, when the invention enters the public domain.

What problem does this patent solve?

Precisely detecting specific nucleic acid sequences within cells or tissues is crucial for understanding diseases like cancer and infections, and for basic biological research. This method aims to improve the accuracy and clarity of such detection by reducing background noise from non-target binding. It provides a tool for scientists to visualize exactly where and how much of a particular genetic material is present in a biological sample.

What does this patent NOT cover?

Does not cover methods that use linear probes instead of circular probes for target nucleic acid detection.

Patent monitoring

Get notified when new matching patents are published

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: October 2, 2026 · PatentBrief is not a law firm and this is not legal advice.